• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社区居住老年人中可能存在的呼吸性肌肉减少症与9年死亡率:来自中国健康与养老追踪调查(CHARLS)的首个纵向证据

Probable respiratory sarcopenia and 9-year mortality in community-dwelling older adults: the first longitudinal evidence from the CHARLS.

作者信息

Zhu Yan, Chen Qifeng, Huang Mingang, Chen Kangkang

机构信息

Emergency Internal Medicine, Shaoxing Seventh People's Hospital (Affiliated Mental Health Center, Medical College of Shaoxing University), Shaoxing, China.

Department of Non-communicable Diseases Control and Prevention, Shaoxing Center for Disease Control and Prevention, 276 Century Street, Shaoxing, 312000, Zhejiang Province, China.

出版信息

Sci Rep. 2025 Sep 26;15(1):33022. doi: 10.1038/s41598-025-18511-y.

DOI:10.1038/s41598-025-18511-y
PMID:41006472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12474932/
Abstract

a position paper by the Japanese Working Group for Respiratory Sarcopenia (JWGRS). However, the clinical values of probable RS remain unclear. Therefore, we conducted a longitudinal study to determine its impacts on short- and long-term all-cause mortality. Our data were extracted from the China Health and Retirement Longitudinal Study. A total of 5,006 participants were selected as a cohort in 2011, and followed up until 2020. According to the JWGRS, probable RS was defined as a coexistence of low respiratory muscle strength and low appendicular skeletal muscles (ASM) mass. Hazard ratios (HRs) for all-cause mortality and cause-specific mortality were calculated through Cox regression analyses. After an average of 9 years of follow up, 1,176 of the 5,006 participants (23.49%) died. Cox proportional hazard regression showed that low ASM mass (HR = 1.24, 95% CI = 1.09-1.41, P < 0.001), low respiratory muscle strength (HR = 1.31, 95% CI = 1.11-1.54, P = 0.001), and probable RS (HR = 1.31, 95% CI = 1.15-1.48, P < 0.001) were associated with increased all-cause mortality. However, when the follow-up period was shortened to 2 years, the association between probable RS and all-cause mortality became non-significant (P = 0.246), although it remained significant for respiratory-related mortality (HR = 3.16, 95% CI = 1.39-7.18, P = 0.006). Diagnosing probable RS and leading to intervention could significantly prevent and reduce the burden of long-term all-cause mortality.

摘要

这是日本呼吸肌减少症工作组(JWGRS)的一篇立场文件。然而,疑似呼吸肌减少症(RS)的临床价值仍不明确。因此,我们进行了一项纵向研究,以确定其对短期和长期全因死亡率的影响。我们的数据来自中国健康与养老追踪调查。2011年共选取5006名参与者作为队列,并随访至2020年。根据JWGRS的标准,疑似RS被定义为呼吸肌力量低和四肢骨骼肌(ASM)质量低同时存在。通过Cox回归分析计算全因死亡率和特定原因死亡率的风险比(HRs)。平均随访9年后,5006名参与者中有1176人(23.49%)死亡。Cox比例风险回归显示,低ASM质量(HR = 1.24,95%CI = 1.09 - 1.41,P < 0.001)、低呼吸肌力量(HR = 1.31,95%CI = 1.11 - 1.54,P = 0.001)和疑似RS(HR = 1.31,95%CI = 1.15 - 1.48,P < 0.001)与全因死亡率增加相关。然而,当随访期缩短至2年时,疑似RS与全因死亡率之间的关联变得不显著(P = 0.246),尽管其与呼吸相关死亡率仍显著相关(HR = 3.16,95%CI = 1.39 - 7.18,P = 0.006)。诊断疑似RS并进行干预可显著预防和减轻长期全因死亡率的负担。

相似文献

1
Probable respiratory sarcopenia and 9-year mortality in community-dwelling older adults: the first longitudinal evidence from the CHARLS.社区居住老年人中可能存在的呼吸性肌肉减少症与9年死亡率:来自中国健康与养老追踪调查(CHARLS)的首个纵向证据
Sci Rep. 2025 Sep 26;15(1):33022. doi: 10.1038/s41598-025-18511-y.
2
Respiratory sarcopenia as a mortality predictor for chronic kidney disease: a dual-cohort longitudinal study.
Ren Fail. 2025 Dec;47(1):2587375. doi: 10.1080/0886022X.2025.2587375. Epub 2025 Nov 18.
3
Influence of probable respiratory sarcopenia on chronic lung diseases: a population-based cohort study of community-dwelling Chinese older adults.可能存在的呼吸性肌肉减少症对慢性肺部疾病的影响:一项基于人群的中国社区居住老年人队列研究。
Front Med (Lausanne). 2025 Aug 19;12:1617808. doi: 10.3389/fmed.2025.1617808. eCollection 2025.
4
Incidence and influencing factors for respiratory sarcopenia in older adults: The first longitudinal evidence from the CHARLS.老年人呼吸肌减少症的发生率及影响因素:来自 CHARLS 的首个纵向证据。
Geriatr Gerontol Int. 2024 Oct;24(10):1015-1021. doi: 10.1111/ggi.14964. Epub 2024 Aug 22.
5
Validating respiratory sarcopenia diagnostic criteria by mortality based on a position paper by four professional organizations: Insights from the Otassha study.基于四个专业组织的立场文件,通过死亡率验证呼吸肌减少症的诊断标准:来自 Otassha 研究的见解。
Geriatr Gerontol Int. 2024 Sep;24(9):948-953. doi: 10.1111/ggi.14937. Epub 2024 Aug 6.
6
Association between possible sarcopenia, all-cause mortality, and adverse health outcomes in community-dwelling older adults in China.中国社区居住的老年人中可能的肌肉减少症与全因死亡率和不良健康结局的关系。
Sci Rep. 2024 Oct 29;14(1):25913. doi: 10.1038/s41598-024-77725-8.
7
Association of possible sarcopenia and its components with all-cause mortality in a middle-aged and older population: a 9-year cohort study.中年及老年人群中潜在肌肉减少症及其组成部分与全因死亡率的关联:一项9年队列研究
Sci Rep. 2025 Aug 20;15(1):30481. doi: 10.1038/s41598-025-16034-0.
8
Sarcopenia: an independent predictor of mortality in community-dwelling older Korean men.肌肉减少症:社区居住的韩国老年男性死亡率的独立预测因子。
J Gerontol A Biol Sci Med Sci. 2014 Oct;69(10):1244-52. doi: 10.1093/gerona/glu050. Epub 2014 Apr 10.
9
High-density lipoprotein cholesterol level and risk of muscle strength decline and sarcopenia in older adults.高密度脂蛋白胆固醇水平与老年人肌肉力量下降和肌肉减少症的风险。
Clin Nutr. 2024 Oct;43(10):2289-2295. doi: 10.1016/j.clnu.2024.08.017. Epub 2024 Aug 22.
10
Longitudinal analysis of sleep duration trajectories and sarcopenia risk in middle-aged and older Chinese adults: evidence from China health and retirement longitudinal study.
BMJ Open. 2025 Dec 23;15(12):e106030. doi: 10.1136/bmjopen-2025-106030.

本文引用的文献

1
Association between sarcopenia and frailty in middle-aged and elder population: Findings from the China health and retirement longitudinal study.肌少症与中老年人群衰弱的关系:来自中国健康与养老追踪调查的发现。
J Glob Health. 2024 Aug 16;14:04163. doi: 10.7189/jogh.14.04163.
2
Validating respiratory sarcopenia diagnostic criteria by mortality based on a position paper by four professional organizations: Insights from the Otassha study.基于四个专业组织的立场文件,通过死亡率验证呼吸肌减少症的诊断标准:来自 Otassha 研究的见解。
Geriatr Gerontol Int. 2024 Sep;24(9):948-953. doi: 10.1111/ggi.14937. Epub 2024 Aug 6.
3
Automated evaluation of diaphragm configuration based on chest CT in COPD patients.基于胸部CT对慢性阻塞性肺疾病(COPD)患者膈肌形态的自动评估
Eur Radiol Exp. 2024 Aug 1;8(1):87. doi: 10.1186/s41747-024-00491-9.
4
Bidirectional transitions of sarcopenia states in older adults: The longitudinal evidence from CHARLS.老年人肌肉减少症状态的双向转变:来自中国健康与养老追踪调查(CHARLS)的纵向证据
J Cachexia Sarcopenia Muscle. 2024 Oct;15(5):1915-1929. doi: 10.1002/jcsm.13541. Epub 2024 Jul 12.
5
Characteristics of Skeletal Muscle Strength in Subjects With Interstitial Lung Disease.间质性肺疾病患者的骨骼肌力量特征。
Arch Phys Med Rehabil. 2024 Jun;105(6):1099-1105. doi: 10.1016/j.apmr.2024.01.006. Epub 2024 Jan 24.
6
Evaluation of patients with chronic obstructive pulmonary disease by maximal inspiratory pressure and diaphragmatic excursion with ultrasound sonography.超声检查最大吸气压力和膈肌移动度评估慢性阻塞性肺疾病患者。
Respir Investig. 2024 Mar;62(2):234-239. doi: 10.1016/j.resinv.2023.12.013. Epub 2024 Jan 17.
7
The longitudinal bidirectional association between sarcopenia and cognitive function in community-dwelling older adults: Findings from the China Health and Retirement Longitudinal Study.社区老年人肌少症与认知功能的纵向双向关联:来自中国健康与养老追踪调查的研究结果。
J Glob Health. 2023 Dec 27;13:04182. doi: 10.7189/jogh.13.04182.
8
Definition, diagnosis, and treatment of respiratory sarcopenia.呼吸肌少肌症的定义、诊断与治疗
Curr Opin Clin Nutr Metab Care. 2024 May 1;27(3):210-218. doi: 10.1097/MCO.0000000000001003. Epub 2023 Nov 29.
9
Respiratory sarcopenia is a predictor of all-cause mortality in community-dwelling older adults-The Otassha Study.呼吸肌少症是社区居住老年人全因死亡率的预测因素——尾鹫研究
J Cachexia Sarcopenia Muscle. 2023 Aug;14(4):1894-1899. doi: 10.1002/jcsm.13266. Epub 2023 Jun 14.
10
Association of muscle wasting with mortality risk among adults: A systematic review and meta-analysis of prospective studies.肌肉减少症与成年人死亡风险的相关性:一项前瞻性研究的系统评价和荟萃分析。
J Cachexia Sarcopenia Muscle. 2023 Aug;14(4):1596-1612. doi: 10.1002/jcsm.13263. Epub 2023 May 20.